TCRX Competitors & Alternatives
Compare Tscan Therapeutics Inc with similar stocks in the same industry
Biotechnology
TCRX
Main Stock$0.17
Tradestie Score
50
Market Cap
$118.60M
Revenue Growth
-0.7%
Analyst Upside
+475.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRZN
Surrozen, Inc. Common
|
$32.02
|
$117.07M | - | 30 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$2.00
|
$112.28M | - | 51 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.05
|
$110.20M | - | 41 | Compare |
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$0.22
|
$106.00M | - | 50 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.56
|
$97.42M | - | 50 | Compare |
|
HOWL
Werewolf Therapeutics, Inc. Common Stock
|
$0.98
|
$89.17M | - | 45 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 41 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.20
|
$67.94M | - | 46 | Compare |
|
IPSC
Century Therapeutics, Inc. Common Stock
|
$1.64
|
$43.18M | - | 30 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$0.85
|
$10.26M | - | 58 | Compare |
More TCRX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry